Subramanian Krishnakumar Selected Research

Subramanian Krishnakumar Research Topics

Disease

84	Neoplasms (Cancer) 02/2022 - 07/2003
66	Retinoblastoma (Glioblastoma, Retinal) 08/2022 - 03/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2003
10	Melanoma (Melanoma, Malignant) 03/2021 - 08/2003
8	Carcinogenesis 08/2016 - 06/2007
8	Uveal melanoma 01/2016 - 08/2003
5	Breast Neoplasms (Breast Cancer) 02/2019 - 01/2013
4	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022 - 02/2003
4	Carcinoma (Carcinomatosis) 02/2022 - 07/2003
3	Retinal Detachment (Retinal Detachments) 07/2021 - 11/2008
2	Cataract (Cataracts) 07/2021 - 01/2019
2	Lymphoma (Lymphomas) 07/2021 - 01/2013
2	Circulating Neoplastic Cells 07/2017 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2016 - 04/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 10/2009
2	Monosomy 01/2016 - 10/2009
2	Colonic Neoplasms (Colon Cancer) 01/2015 - 01/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2005 - 09/2003
2	Carcinoma in Situ 04/2005 - 09/2003
2	Disease Progression 04/2005 - 09/2003
1	Renal Insufficiency (Renal Failure) 01/2024
1	Amblyopia (Lazy Eye) 06/2023
1	Lacrimal Duct Obstruction 08/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Atrophy 07/2021
1	Anterior Uveitis 07/2021
1	Embryonal Rhabdomyosarcoma 12/2020
1	Scleritis (Episcleritis) 09/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2019
1	Brain Neoplasms (Brain Tumor) 09/2018
1	Geographic Atrophy 03/2017

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 08/2022 - 02/2003
19	Epithelial Cell Adhesion MoleculeIBA 11/2020 - 12/2004
13	MicroRNAs (MicroRNA)IBA 10/2020 - 10/2009
10	SurvivinIBA 10/2016 - 10/2013
8	Small Interfering RNA (siRNA)IBA 11/2020 - 07/2011
8	Monoclonal AntibodiesIBA 01/2013 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 04/2010
7	Retinaldehyde (Retinal)IBA 01/2022 - 04/2010
7	ParaffinIBA 10/2009 - 06/2004
6	CurcuminIBA 01/2015 - 10/2009
6	Histocompatibility Antigens Class IIBA 04/2005 - 08/2003
5	LigandsIBA 01/2017 - 03/2007
5	EnzymesIBA 01/2016 - 07/2003
5	Histocompatibility Antigens Class IIIBA 03/2004 - 08/2003
4	Peptides (Polypeptides)IBA 12/2017 - 09/2003
4	NucleolinIBA 07/2017 - 04/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2009
4	LipidsIBA 08/2016 - 01/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 08/2006 - 09/2003
3	Phosphotransferases (Kinase)IBA 06/2018 - 05/2010
3	GoldIBA 12/2017 - 01/2013
3	locked nucleic acidIBA 07/2017 - 09/2015
3	Messenger RNA (mRNA)IBA 10/2016 - 11/2015
3	Phosphatidylcholines (Phosphatidylcholine)IBA 08/2016 - 09/2013
3	CytokinesIBA 08/2016 - 01/2012
3	APTIBA 08/2016 - 02/2015
3	Carrier Proteins (Binding Protein)IBA 01/2016 - 12/2003
3	StathminIBA 12/2015 - 07/2011
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2015 - 01/2013
3	AntagomirsIBA 02/2015 - 01/2014
3	multidrug resistance-associated protein 1IBA 01/2015 - 04/2007
3	Histocompatibility Antigens (Histocompatibility Antigen)IBA 03/2004 - 09/2003
3	tapasinIBA 03/2004 - 09/2003
3	CalnexinIBA 03/2004 - 09/2003
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 06/2007
2	ZinostatinIBA 01/2017 - 01/2016
2	Nucleotide AptamersIBA 01/2016 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 09/2012
2	AntioxidantsIBA 01/2016 - 09/2012
2	Vincristine (Oncovin)FDA LinkGeneric 01/2015 - 07/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2011
2	CeruleninIBA 01/2013 - 06/2012
2	Complementary DNA (cDNA)IBA 01/2013 - 01/2013
2	Mitogen-Activated Protein KinasesIBA 01/2012 - 05/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2011 - 01/2011
2	Formaldehyde (Formol)FDA Link 10/2009 - 06/2004
1	Cystatin CIBA 01/2024
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Periodic AcidIBA 10/2021
1	Rituximab (Mabthera)FDA Link 07/2021
1	Immunoglobulin G (IgG)IBA 09/2020
1	SaporinsIBA 02/2019
1	PolymersIBA 01/2019
1	HMGA ProteinsIBA 09/2018
1	Sirtuin 1IBA 06/2018
1	Histones (Histone)IBA 06/2018
1	Propidium (Propidium Iodide)IBA 01/2017
1	OligonucleotidesIBA 01/2017
1	N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA 01/2017

Therapy/Procedure

23	Therapeutics 06/2023 - 12/2004
12	Drug Therapy (Chemotherapy) 12/2020 - 12/2003
4	Radiotherapy 03/2021 - 12/2003
2	Immunotherapy 01/2020 - 01/2012
1	Dacryocystorhinostomy 08/2022
1	Cryotherapy (Therapy, Cold) 02/2022
1	Endotamponade 01/2019
1	Vitrectomy 01/2019
1	Combined Modality Therapy 09/2018
1	Adjuvant Chemotherapy 01/2017